Herpes simplex encephalitis (HSE) diagnosis requires brain biopsy for confirmation. Clinical and neurodiagnostic findings can predict HSE in 83% of cases but may yield false positives.
Area of Science:
Neurology
Virology
Infectious Diseases
Background:
Herpes simplex encephalitis (HSE) is a severe neurological condition.
Antiviral agents are evaluated for HSE treatment.
Purpose of the Study:
To analyze clinical data from 113 patients with virologically confirmed HSE.
To evaluate diagnostic methods for HSE.
Main Methods:
Clinical data collection from 113 patients with confirmed HSE.
Analysis of neurodiagnostic aids including EEG, technetium scans, and CT scans.
Logistic regression model for variable selection to predict diagnosis.
Main Results:
HSE occurred across all ages and sexes, nonseasonally.
Characteristic symptoms include behavioral changes, fever, confusion, and speech disturbances.
EEG was the most useful neurodiagnostic aid, followed by technetium and CT scans.
Clinical and neurodiagnostic tests predicted HSE in 83% of cases, with 25% false positives.
Focal findings were present in most patients, including those without HSE.
Cerebrospinal fluid (CSF) and brain scans were often normal in confirmed HSE cases.
Conclusions:
Diagnosis of HSE can only be definitively confirmed by brain biopsy.
Clinical and neurodiagnostic findings are valuable but not solely sufficient for diagnosis.